secwatch.observer — SEC 8-K summary
======================================

Issuer:     RadNet, Inc. (RDNT)
CIK:        0000790526
Form:       8-K
Filed at:   2022-01-24T23:59:59+00:00
Accession:  0001683168-22-000403
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RadNet acquires AI firms Aidence and Quantib for ~$95M combined; issues 2.1M shares
--------------------------------------------------------------------------------

- Aidence acquired for ~$50M (incl. $10M milestones); Quantib for ~$45M.
- Issued 1,141,234 shares for Aidence and 965,058 shares for Quantib to stakeholders.
- Adds AI for lung nodule (Aidence) and prostate/brain MRI (Quantib) to DeepHealth division.
- Quantib products have FDA 510(k) clearance; Aidence's Veye pending FDA approval.
- Dr. Gregory Sorensen to lead combined AI initiatives across all three entities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/0001683168-22-000403-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/radnet_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-000403

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer